Nektar (NKTR) reports agreement to sell Cimzia(R) and Mircera(R) royalties to Royalty Pharma for $124M
Tweet
Share
E-mailGet Alerts NKTR Hot Sheet
Join SI Premium – FREE
Nektar (Nasdaq: NKTR) reports agreement to sell Cimzia(R) and Mircera(R) royalties to Royalty Pharma for $124M
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Reinstates Nektar Therapeutics (NKTR) at Neutral
- Virtu Financial said to explore $3.5B sales of brokerage unit
- reAlpha completes $8.5M InstaMortgage acquisition
Create E-mail Alert Related Categories
Mergers and Acquisitions, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
